RenovoRx, Inc. stock is traded on the Nasdaq Stock Market under the ticker symbol RNXT. RenovoRx, Inc. is in the Biotechnology & Medical Research industry.
RenovoRx, Inc. is a clinical-stage biopharmaceutical company. The Company is developing targeted combination therapies for high unmet medical needs with a goal of improving therapeutic outcomes for cancer patients undergoing treatment. Its Trans-Arterial Micro-Perfusion (TAMP) therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy’s toxicities versus systemic intravenous therapy. Its portfolio of cancer therapies is based on its lead product candidate, RenovoGem (gemcitabine delivered via its delivery system). Its phase III lead product candidate, RenovoGem, is a novel oncology drug-device combination product. RenovoGem is being evaluated for the treatment of locally advanced pancreatic cancer (LAPC) by the Center for Drug Evaluation and Research. Its phase III registrational trial of RenovoGem for the treatment of LAPC is called TIGeR-PaC.
Stock Ticker Symbol Lookup
Here you can look up another stock ticker symbol.
Stock Ticker Symbol TKLF
Here is another stock ticker symbol that we have information about!
Contact | Disclaimer | Copyright | Privacy